Missing/wrong data?
Log in to edit
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype
scientific article
Author/s
author: Enrico Ricevuto, Corrado Ficorella, Katia Cannita
Work details
Publication date
November 15, 2013
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.